News

Attempting to reap these benefits without the safety concerns has led to the development of micropulse (MP) TSCPC, which differs from CW-TSCPC in that the energy to the ciliary body is delivered ...
How Brian Emerick and Micropulse shed customers in an effort to focus on one industry and become an expert — and an incubator. COLUMBIA CITY, Indiana — Brian Emerick wanted to be a farmer. This was ...
May 4, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced the presentation of data demonstrating the safety and efficacy of its proprietary MicroPulse® technology for treating ...
This study highlights the sustained safety and efficacy of MicroPulse Transscleral Laser Therapy (TLT) (also referred to as Transscleral Cyclophotocoagulation) in managing both primary and ...
The study, titled "MicroPulse Transscleral Laser Therapy: A Prospective UK Study," is set to expand Iridex’s global clinical portfolio, through its commitment to funding essential components of ...
Iridex is the exclusive provider of MicroPulse ® devices that utilize the patented technology. Revolutionizing Eye Care with Precision and Safety The patented technology delivers a state-of-the ...
MicroPulse transscleral laser therapy does not reach damaging core tissue temperatures. NEW ORLEANS — In this Healio Video Perspective from the ARVO meeting, Kevin LaMarche discusses thermal ...